Cargando…

The Effectiveness and Tolerability of Glycopyrronium for Patients with Chronic Obstructive Pulmonary Disease in a Clinical Setting: GLARE-Taiwan

Glycopyrronium (GLY) is a pharmacological maintenance treatment for chronic obstructive pulmonary disease (COPD). However, its effectiveness and tolerability for COPD patients in routine clinical practice have not been well-investigated. This study aimed to assess the effectiveness of GLY on health-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Wei-Chang, Lin, Sheng-Hao, Hang, Liang-Wen, Lin, Ching-Hsiung, Hsu, Jeng-Yuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9604569/ https://www.ncbi.nlm.nih.gov/pubmed/36294532 http://dx.doi.org/10.3390/jcm11206210

Ejemplares similares

Comparing Clinical Outcomes of Tiotropium/Olodaterol, Umeclidinium/Vilanterol, and Indacaterol/Glycopyrronium Fixed-Dose Combination Therapy in Patients with Chronic Obstructive Pulmonary Disease in Taiwan: A Multicenter Cohort Study
por: Hsieh, Meng-Jer, et al.
Publicado: (2022)

Population-based case–control study of the effect of sun glare on pedestrian fatalities in Taiwan
por: Ma, Hon-Ping, et al.
Publicado: (2019)

Direct Switch from Tiotropium to Indacaterol/Glycopyrronium in Chronic Obstructive Pulmonary Disease Patients in Korea
por: Lee, Sang Haak, et al.
Publicado: (2021)

A Glaring Paradox
por: Johnston, Mark
Publicado: (2015)

Cost-effectiveness of tiotropium versus usual care and glycopyrronium in the treatment of chronic obstructive pulmonary disease in Sweden
por: Eklund, Oskar, et al.
Publicado: (2015)

Predictive factors warrant screening for obstructive sleep apnea in COPD: a Taiwan National Survey
por: Hang, Liang-Wen, et al.
Publicado: (2016)

Risk factors for osteoporosis in male patients with chronic obstructive pulmonary disease in Taiwan
por: Lin, Chu-Hsu, et al.
Publicado: (2018)

The switching glare illusion: Appearance and disappearance of glare effect due to figure-ground reversal
por: Yamagata, Risa, et al.
Publicado: (2023)

Cost-effectiveness of umeclidinium compared with tiotropium and glycopyrronium as monotherapy for chronic obstructive pulmonary disease: a UK perspective
por: Shah, Dhvani, et al.
Publicado: (2018)

Some Remarks on Glare Retinalgia
por: Elliot, R. H.
Publicado: (1898)

NICEFIT—A Prospective, Non-Interventional, and Multicentric Study for the Management of Idiopathic Pulmonary Fibrosis with Antifibrotic Therapy in Taiwan
por: Cheng, Shih-Lung, et al.
Publicado: (2022)

Susceptibility to pattern glare following stroke
por: Beasley, Ian G., et al.
Publicado: (2012)

Pattern glare: the effects of contrast and color
por: Monger, Laura J., et al.
Publicado: (2015)

Cost-effectiveness of tiotropium versus glycopyrronium in moderate to very severe chronic obstructive pulmonary disease in Canada, Spain, Sweden, and the UK
por: Eklund, Oskar, et al.
Publicado: (2016)

Efficacy and safety of once-daily glycopyrronium in predominantly Chinese patients with moderate-to-severe chronic obstructive pulmonary disease: the GLOW7 study
por: Wang, Chen, et al.
Publicado: (2015)

Real-life therapeutic effects of beclomethasone dipropionate/formoterol fumarate/glycopyrronium combined triple therapy in patients with chronic obstructive pulmonary disease
por: Pelaia, Corrado, et al.
Publicado: (2023)

COPD in Taiwan: a National Epidemiology Survey
por: Cheng, Shih-Lung, et al.
Publicado: (2015)

The impact of 2011 and 2017 Global Initiative for Chronic Obstructive Pulmonary Disease (GOLD) guidelines on allocation and pharmacological management of patients with COPD in Taiwan: Taiwan Obstructive Lung Disease (TOLD) study
por: Hsieh, Meng-Jer, et al.
Publicado: (2018)

Explainable Machine Learning Model for Predicting First-Time Acute Exacerbation in Patients with Chronic Obstructive Pulmonary Disease
por: Kor, Chew-Teng, et al.
Publicado: (2022)

Once-daily glycopyrronium bromide, a long-acting muscarinic antagonist, for chronic obstructive pulmonary disease: a systematic review of clinical benefit
por: Ulrik, Charlotte Suppli
Publicado: (2012)

Clinical benefit of fixed-dose dual bronchodilation with glycopyrronium and indacaterol once daily in patients with chronic obstructive pulmonary disease: a systematic review
por: Ulrik, Charlotte Suppli
Publicado: (2014)

Randomized study of the safety, pharmacokinetics, and bronchodilatory efficacy of a proprietary glycopyrronium metered-dose inhaler in study patients with chronic obstructive pulmonary disease
por: Rennard, Stephen, et al.
Publicado: (2014)

Efficacy and safety of once-daily glycopyrronium in predominantly Chinese patients with moderate-to-severe chronic obstructive pulmonary disease: the GLOW7 study [Corrigendum]
Publicado: (2015)

Evaluation of systemic absorption and bronchodilator effect of glycopyrronium bromide delivered by nebulizer or a dry powder inhaler in subjects with chronic obstructive pulmonary disease
por: Leaker, Brian R., et al.
Publicado: (2019)

Real-world Safety and Efficacy of Indacaterol/Glycopyrronium in Japanese Patients with Chronic Obstructive Pulmonary Disease: A 52-week Post-marketing Surveillance
por: Kato, Chihiro, et al.
Publicado: (2021)

Cost-Effectiveness Analysis of Triple Therapy with Budesonide/ Glycopyrronium/ Formoterol Fumarate versus Dual Therapy in Patients with Chronic Obstructive Pulmonary Disease in Spain
por: Trigueros, Juan Antonio, et al.
Publicado: (2022)

Comparative Effectiveness of Umeclidinium/Vilanterol versus Indacaterol/Glycopyrronium on Moderate-to-Severe Exacerbations in Patients with Chronic Obstructive Pulmonary Disease in Clinical Practice in England
por: Requena, Gema, et al.
Publicado: (2023)

The Risk of Erectile Dysfunction in Chronic Obstructive Pulmonary Disease: A Population-Based Cohort Study in Taiwan
por: Shen, Te-Chun, et al.
Publicado: (2015)

Automatic Laser Glare Suppression in Electro-Optical Sensors
por: Ritt, Gunnar, et al.
Publicado: (2015)

The Glare Effect Test and the Impact of Age on Luminosity Thresholds
por: Facchin, Alessio, et al.
Publicado: (2017)

Spatial–Spectral Evidence of Glare Influence on Hyperspectral Acquisitions
por: Signoroni, Alberto, et al.
Publicado: (2020)

High level of pattern glare in major depressive disorder
por: Qi, Xiongwei, et al.
Publicado: (2019)

Multiple Impact Damage in GLARE Laminates: Experiments and Simulations
por: Lee, Sang-Eui, et al.
Publicado: (2021)

Mortality and morbidity of asthma and chronic obstructive pulmonary disease associated with ambient environment in metropolitans in Taiwan
por: Zafirah, Yasmin, et al.
Publicado: (2021)

Performance and Clinical Utility of Various Chronic Obstructive Pulmonary Disease Case-Finding Tools
por: Chen, Chiung-Zuei, et al.
Publicado: (2021)

Mesenchymal Stem Cell Administration in Patients with Chronic Obstructive Pulmonary Disease: State of the Science
por: Cheng, Shih-Lung, et al.
Publicado: (2017)

Evaluating the association of osteoporosis with inhaled corticosteroid use in chronic obstructive pulmonary disease in Taiwan
por: Chiu, Kai-Lin, et al.
Publicado: (2021)

Comparative efficacy and safety of glycopyrronium/formoterol fixed-dose combination versus glycopyrronium monotherapy in patients with moderate-to–severe COPD
por: Salvi, Sundeep, et al.
Publicado: (2022)

Blood monocyte levels predict the risk of acute exacerbations of chronic obstructive pulmonary disease: a retrospective case–control study
por: Lin, Ching-Hsiung, et al.
Publicado: (2022)

The influence of spectral composition on discomfort glare for large-size sources
por: Berman, Sam M, et al.
Publicado: (1995)

Cannot write session to /tmp/vufind_sessions/sess_ei4gp97rkpb7f12s4pbf9d920t